| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $206.3M | -22.9% |
| SG&A Expense | $71.0M | -3.7% |
| Operating Income | -$277.3M | +18.8% |
| Interest Expense | $13K | -27.8% |
| Pre-tax Income | $260.4M | -22.0% |
| Income Tax | $33K | +0.0% |
| Net Income | -$260.5M | +22.0% |
| EPS (Basic) | -$4.97 | +22.2% |
| EPS (Diluted) | -$4.97 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $285.5M | +49.9% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $289.3M | -40.5% |
| Total Assets | $479.4M | -28.1% |
| Current Liabilities | $41.7M | -20.5% |
| Total Liabilities | $213.6M | -7.3% |
| Stockholders' Equity | $265.8M | -39.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$154.2M | +25.3% |
| Capital Expenditures | $41.4M | +11.7% |
| Investing Cash Flow | $249.2M | +174.1% |
| Financing Cash Flow | $31K | -98.4% |
| Free Cash Flow | -$195.5M | +19.7% |
| +22.2% |